307 related articles for article (PubMed ID: 205786)
21. Middle molecular weight substances and uremic polyneuropathy.
Dukanović L; Petrović J; Potić J
Acta Med Iugosl; 1990; 44(2):117-28. PubMed ID: 2162129
[TBL] [Abstract][Full Text] [Related]
22. The effect of alterations of uremic retention products upon platelet and peripheral nerve function.
Lindsay RM; Bolton CF; Clark WF; Linton AL
Clin Nephrol; 1983 Mar; 19(3):110-5. PubMed ID: 6839559
[TBL] [Abstract][Full Text] [Related]
23. The beneficial effect of ketoacids on serum phosphate and parathyroid hormone in patients with chronic uremia.
Schaefer K; von Herrath D; Asmus G; Umlauf E
Clin Nephrol; 1988 Aug; 30(2):93-6. PubMed ID: 3180519
[TBL] [Abstract][Full Text] [Related]
24. Motor action potential (M.A.P.) in the evaluation of uremic peripheral neurone damage: influence of middle molecules (M.M.).
Coratelli P; Giannattasio M; Corciulo R; Petrarulo F; Passavanti G; Ferrannini E; Amerio A
Life Support Syst; 1983; 1 Suppl 1():129-32. PubMed ID: 6101046
[No Abstract] [Full Text] [Related]
25. The search for uremic toxin(s) "X" "X" = PTH.
Massry SG; Goldstein DA
Clin Nephrol; 1979 Apr; 11(4):181-9. PubMed ID: 572276
[No Abstract] [Full Text] [Related]
26. Uremic syndrome in man: new evidence for parathormone as a multisystem neurotoxin.
Avram MM; Iancu M; Morrow P; Feinfeld D; Huatuco A
Clin Nephrol; 1979 Feb; 11(2):59-62. PubMed ID: 455810
[No Abstract] [Full Text] [Related]
27. Uremic polyneuropathy: a clinical and electrophysiological study in 135 short- and long-term hemodialyzed patients.
Bazzi C; Pagani C; Sorgato G; Albonico G; Fellin G; D'Amico G
Clin Nephrol; 1991 Apr; 35(4):176-81. PubMed ID: 1649712
[TBL] [Abstract][Full Text] [Related]
28. Second lumbrical-interossei latency difference: A strong predictor of median neuropathy at the wrist in uremic patients.
Sharma VK; Wilder-Smith EP
Neurol Neurophysiol Neurosci; 2007 Jul; ():2. PubMed ID: 17700926
[TBL] [Abstract][Full Text] [Related]
29. Comparison of motor and sensory nerve conduction velocity in early uremic polyneuropathy.
Jebsen RH; Tenckhoff H
Arch Phys Med Rehabil; 1969 Mar; 50(3):124-6. PubMed ID: 4304421
[No Abstract] [Full Text] [Related]
30. Parathyroid hormone as a uremic toxin: its influence on T lymphocyte receptors.
Giacchino F; Quattrocchio G; Piccoli G
Clin Nephrol; 1985 Feb; 23(2):105-6. PubMed ID: 3872757
[No Abstract] [Full Text] [Related]
31. Cellular immunity and levels of parathyroid hormone in uremic patients receiving hemodialysis.
Griveas I; Visvardis G; Papadopoulou D; Mitsopoulos E; Kyriklidou P; Manou E; Meimaridou D; Ginikopoulou E; Sakellariou G; Fleva A; Zilidou R; Paulitou A
Ren Fail; 2005; 27(3):275-8. PubMed ID: 15957542
[TBL] [Abstract][Full Text] [Related]
32. Immunologic disturbances and levels of parathyroid hormone in uremic patients in replacement dialysis therapy.
Angelini D; Carlini A; Mazzotta L; Mei E; Grassi R; Giusti R; Neri M; Fiorini I; Antonelli A
Clin Nephrol; 1994 Oct; 42(4):246-50. PubMed ID: 7834917
[TBL] [Abstract][Full Text] [Related]
33. Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia.
Rao DS; Shih MS; Mohini R
N Engl J Med; 1993 Jan; 328(3):171-5. PubMed ID: 8417383
[TBL] [Abstract][Full Text] [Related]
34. [Parathormone and peripheral neuropathy in patients on chronic hemodialysis].
Kostić SM; Djordjević V; Stefanović V
Srp Arh Celok Lek; 1985; 113(5-6):467-72. PubMed ID: 3003934
[No Abstract] [Full Text] [Related]
35. The influence of glomerular filtration rate on uremic polyneuropathy.
Savazzi GM; Migone L; Cambi V
Clin Nephrol; 1980 Feb; 13(2):64-72. PubMed ID: 6244910
[No Abstract] [Full Text] [Related]
36. Influence of sevelamer hydrochloride on serum concentration of whole (1-84) and N-terminally truncated (7-84) parathyroid hormone fragments in hemodialysis uremic patients.
Chudek J; Piecha G; Kokot F; Wiecek A
J Nephrol; 2003; 16(5):710-5. PubMed ID: 14733418
[TBL] [Abstract][Full Text] [Related]
37. [Neural conduction velocity in uremic neuropathy].
Parisen Toldin P; Pisani E; D'Andrea G; Lagreca G; Ferro Milone F
Riv Neurobiol; 1978; 24(1-2):5-12. PubMed ID: 231817
[No Abstract] [Full Text] [Related]
38. Parathormone as a nerve poison in uremia.
Di Giulio S; Chkoff N; Lhoste F; Zingraff J; Drüeke T
N Engl J Med; 1978 Nov; 299(20):1134-5. PubMed ID: 703796
[No Abstract] [Full Text] [Related]
39. Osmotic fragility of erythrocytes, cell deformability and secondary hyperparathyroidism in uremic patients on maintenance hemodialysis.
Docci D; del Vecchio C; Salvi P; Turci F; Salvi G; Cenciotti L; Pretolani E
Clin Nephrol; 1985 Feb; 23(2):68-73. PubMed ID: 3987101
[TBL] [Abstract][Full Text] [Related]
40. Motor and sensory nerve conduction in uremic patients undergoing repeated dialysis.
Codish SD; Cress RH
Arch Phys Med Rehabil; 1971 Jun; 52(6):260-3. PubMed ID: 5090268
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
